Zobrazeno 1 - 2
of 2
pro vyhledávání: '"K.M. Altunda"'
Autor:
Mustafa Solak, K.M. Altunda, Taner Babacan, Furkan Sarici, Hilbrahim Petekkaya, Zafer Arik, Ozge Keskin, F. Paksoy Türköz
Publikováno v:
Annals of Oncology. 23:ix543-ix544
Background Altough clinical differences between breast cancer (BC) subtypes have been well-described, etiologic heterogeneity have not been fully studied. The aim of this study was to assess the associations between risk factors and molecular subtype
Autor:
Shinsuke Saisho, P. Mitchell, Dimitrios Mougiakakos, K. Tsolakis, E. Patsouris, Deog-Yeon Jo, J. Mobley, N.G. Tsoukalas, Bryan C. Fuchs, K.S. Lee, Y. Akashi, S. Koeck, I.C. Song, Z. Milovanovic, H. Petekkaya, L. Bodnar, Norio Okumura, M. Bitsche, K. Nakano, M. Inomata, Jin Soo Kim, J.F. Bernaudin, Rolf Kiessling, A. Karameris, Z. Tomasevic, Norihiko Ikeda, A. Yelsengekar, M.K. Mallath, H. Wisniewska, J. Huber, T. John, S. Camilleri-Broet, E. Mdemba, Riki Okita, Yasuhiro Kodera, J. Kelm, Noriko Gotoh, S. M. Huang, Stamatios Theocharis, M. Hatmi, H. Gan, M. Zwierzina, D. Kolarevic, P. Russell, H. Iwasaki, Mitsuo Katano, Ioannis K. Kostakis, Yuji Hirami, G. Wright, D. Chen, O. Keskin, Hiroyuki Sugimoto, M.S. Liew, Hyo Jin Lee, M. Lamparska-Przybysz, Takuro Yukawa, S. Barnett, T. Babacan, Carmel Murone, M.P. Roman, T. Oda, K. Yamada, Z. Arık, H. Ryu, Samyong Kim, Ismail Elalamy, S.A. Mehta, I. Sfiniadakis, Tatsuo Ohira, Ai Maeda, W. Jozwicki, M. Wieczorek, F.S. Sarıcı, Tsutomu Fujii, Marzena Walkiewicz, Katsuhiko Shimizu, Masaya Suenaga, Masao Nakata, N. Ohkohchi, A. Tzovaras, G. Gamerith, A. Brozyna, Kenneth K. Tanabe, H. Zwierzina, Y. Ohara, M. Nomura, Andrew M. Scott, W. Hilbe, M. Solak, Hwan Jung Yun, R. Miyamoto, Hideya Onishi, Adi F. Gazdar, J. Fareed, Maria Tolia, A. Stanczak, F. Paksoy Türköz, S. Hashimoto, S. Takeda, P.S. Patil, G. Gerotziafas, A. Amann, K. Yasuda, Suguru Yamada, Goro Nakayama, Costas Giaginis, K.M. Altunda
Publikováno v:
Annals of Oncology. 23:ix541
Background Chemokines and their receptors have been shown to play a critical role in cancer growth and metastasis. In particular, recent data have suggested that the chemokine CXCL12 and its receptor CXCR7 (also known as RDC1), which has been recentl